Novo Nordisk Pharm. Industries Inc.
Novo Nordisk Pharm. Industries Inc. is a leading global healthcare company specializing in diabetes, obesity, cardiovascular, and rare disease treatments, with a strong presence in the U.S. and worldwide.
Novo Nordisk Pharm. Industries Inc. is a leading global healthcare company specializing in diabetes, obesity, cardiovascular, and rare disease treatments, with a strong presence in the U.S. and worldwide.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Novo Nordisk Pharm. Industries Inc. is actively expanding its portfolio of diabetes and obesity treatments, investing in sustainable manufacturing, and enhancing patient access programs in response to rising global demand.
Launch of new obesity and diabetes medications, including Wegovy and Rybelsus.
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Novo Nordisk Pharm. Industries Inc. operates as part of Novo Nordisk, a global pharmaceutical leader focused on developing and manufacturing innovative treatments for chronic diseases such as diabetes, obesity, cardiovascular conditions, and rare disorders. The company is renowned for its scientific excellence, patient-centric approach, and commitment to sustainability. With a century-long legacy, Novo Nordisk serves millions of patients across more than 168 countries.
Plainsboro, New Jersey, USA
1923
NVO
